SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis

T2Covered by 1 source · first reported by YourStory at 06 Oct, 12:06 UTC

SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis The US Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Balloon for coronary in-stent restenosis (ISR), Cordis announced this month. This is the first and only sirolimus drug-eluting b

indiareleases

Sources

• T2SELUTION SLR™ wins historic US FDA nod for in‑stent restenosisYourStory06 Oct, 12:06